MedTrace Logo

Procalcitonin as a Marker of Antibiotic Therapy in Patients With Lower Respiratory Tract Infections

NCT02171338 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2014-08-15

No results posted yet for this study

Summary

The purpose of this study is to investigate weather or not the use of a procalcitonin(PCT)-based treatment in the daily clinical work could lower the consumption of antibiotics in patients with lower respiratory tract infections.

Conditions

  • Pneumonia
  • Acute Exacerbation of Chronic Obstructive Airways Disease

Interventions

OTHER

PCT-level

PCT-level is available to the treating doctor.

BEHAVIORAL

Antibiotic treatment based on PCT-level

PCT-level is available to the treating doctor and the decision whether or not to treat with antibiotic is based on the level of PCT. The type of antibiotic chosen to treat is based on the existing antibiotic treatment guidelines of Holbaek Hospital and includes the antibiotics listed above.

Sponsors & Collaborators

  • Region Sjælland

    collaborator OTHER

  • Aase and Ejnar Danielsens Foundation

    collaborator OTHER

  • Holbaek Sygehus

    lead OTHER

Principal Investigators

  • Hans Ibsen, M.D., D.M.Sc · Holbaek Sygehus

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2014-08-31
Completion
2014-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02171338 on ClinicalTrials.gov